Manufacturer record

Cure Health Pharmaceuticals Pvt Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by Cure Health Pharmaceuticals Pvt Ltd (Himachal Pradesh) was declared Not of Standard Quality in September 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: TG23074A, Azithromycin Tablets IP (exp Feb 2026). FDAL, Maharashtra (state lab) found it not of standard quality: Description. Listed in the September 2025 alert.

Records by type

1 record linked to Cure Health Pharmaceuticals Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Sep 2025 to Sep 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2025
1
Products affected
Description
Most common failure
Sep 2025
Latest alert

Flagged batches per year

2025 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Azithromycin Tablets IP Batch TG23074AMfg Mar 2024 · Exp Feb 2026 DescriptionDescription FDAL, MaharashtraState lab Sep 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.